Dear StartupSearch: Is 23andMe a web-based startup or not?

1. A start-up is a company with a limited operating history (Wikipedia). 2. Startup search “tracks the web technology ecosystem commonly referenced as “Web 2.0.” We collect facts and figures about new web products, startup companies, key startup employees, and the funding dollars powering their growth.” 3. 23andMe is a pioneering web-based, personalized genomics startup… Continue reading Dear StartupSearch: Is 23andMe a web-based startup or not?

Genome Technology launches MethodShare beta!

Genome Technology, the heavy trafficked New York based biotech website (also a printed monthly magazine) just launched the beta version of MethodShare as “a place for people to discuss methods and tools, recommend methods papers to one another” according to Ciara Curtin, senior editor. The site will be coming out of beta soon. How the… Continue reading Genome Technology launches MethodShare beta!

The Spittoon: the eminent corporate blog of 23andMe and Consumer Enabled Research

The personal genomics service 23andMe just launched publicly a corporate blog called The Spittoon that has been internally up for a few weeks. It is a new chapter in biotech corporate blogging. Just like the web page of 23andMe, The Spittoon’s WordPress blog platform, the concept and design is excellent: amongst others you can find… Continue reading The Spittoon: the eminent corporate blog of 23andMe and Consumer Enabled Research

Startup recipe: collect hair at the barber, isolate keratin, regenerate nerves

Biotech entrepreneurs and wantrepreneurs, here is a tip for Ya to launch a regmed business (and don’t forget to market the product as recycled and green) : Winston-Salem Journal: Human hair could hold key to regeneration of nerve tissue, Wake Forest research shows The study, published in the current issue of Biomaterials, found that the… Continue reading Startup recipe: collect hair at the barber, isolate keratin, regenerate nerves

CIRM and NIH stem cell grants to the biotech industry

Different attitudes, same endeavors. 1. The folks at the California Institute of Regenerative Medicine (CIRM) started to offer grants for biotech companies up to $55,000 out of the 3 billion ‘hope’ dollars. San Diego Union Tribune: Industry and academia team up: For the first time in its three-year existence, the state taxpayer-funded stem cell institute… Continue reading CIRM and NIH stem cell grants to the biotech industry

Nature Editor-in-Chief’s changed mind on enhancement drugs for healthy people

Philip Campbell, the open editor-in-chief of Nature was asked by John Brockman under the cover of the 2008 Edge Annual Question: WHAT HAVE YOU CHANGED YOUR MIND ABOUT? WHY? Campbell writes in his thoughtful answer: “I’ve changed my mind about the use of enhancement drugs by healthy people. A year ago, if asked, I’d have… Continue reading Nature Editor-in-Chief’s changed mind on enhancement drugs for healthy people